PPARGC1A and myocardial ischemia: A study of a myocardial ischemia/reperfusion model demonstrated that inhibition of AMPK significantly reduced the expressions of PGC-1α and SIRT3, impaired mitochondrial function, increased mitochondrial oxidative damage, and promoted myocardial injury [30].